We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Lens-Free Microscope Records Analyzable Optical Patterns

By LabMedica International staff writers
Posted on 23 Dec 2009
A lens-free microscope employs light to illuminate objects such as cells or pathogens in a sample, which create light diffraction and interference patterns that can be recorded by an optical detector.

The microscope, dubbed CyMap, was developed by Cancer Research UK (London, UK) scientists and members of the Optical Biochips Consortium. More...
It enables scientists to count the number of cells in a sample, and also to monitor changes over time, such as location, movement, and division. Because the system contains no physical lenses, there is no requirement for focusing or other critical adjustments.

CyMap has potential for use in medical diagnostics systems to quantify and analyze medical samples in hospitals, doctors' surgeries, and clinical laboratories. In addition, the technology could be developed into a compact cell-imaging system for use in research laboratories.

Dr Phil L'Huillier, Cancer Research Technology (CRT; London, UK) director of business management said: "We believe it can be used to cast light on key biological processes, or to develop new hand-held diagnostic devices. Although primarily designed to monitor the characteristics of cancer cells, the device has strong potential in a wide range of other health science fields."

The lens-free microscope won first prize in the Medical and Healthcare category at The Engineer awards. It also won the overall Grand Prix prize at the event, which focused on and celebrated technology and innovation. The 2009 Engineer awards were held at The Royal Society on December 4, 2009.

Related Links:

Cancer Research UK
Cancer Research Technology



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.